Exhibit 7.01

Joint Filing Agreement

In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree to the joint filing with all other Reporting Persons (as such term is defined in the Schedule 13D referred to below) on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Ordinary Shares, par value US$0.01 per share, of Simcere Pharmaceutical Group, a Cayman Islands company, and that this Agreement may be included as an Exhibit to such joint filing. This Agreement may be executed in any number of counterparts all of which, taken together, shall constitute one and the same instrument.

Signature Page

IN WITNESS WHEREOF, the undersigned hereby execute this agreement as of September 4, 2013.


KING VIEW DEVELOPMENT INTERNATIONAL LIMITED

By:		/s/ Shujun Li
		Shujun Li
		Authorized Representative

TRUSTBRIDGE PARTNERS II, L.P. Acting by its general partner TB Partners GP Limited

By:		/s/ Shujun Li
		Shujun Li
		Authorized Representative

TB PARTNERS GP2, L.P.

By:		/s/ Shujun Li
		Shujun Li
		Authorized Representative

TB PARTNERS GP Limited

By:		/s/ Shujun Li
		Shujun Li
		Authorized Representative

Simcere Pharmaceutical Group SC 13D